Top Markets
Coin of the day
IMBdx IMBdx

IMBdx

461030
Kedudukan dalam Saham #27729
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Harga Saham
$2.17
Modal Pasaran
$31.07M
Perubahan (1 hari)
1.62%
Perubahan (1 tahun)
-61.54%
Negara
KR
Perdagangan IMBdx (461030)

Kategori

Bilangan saham terbitan bagi IMBdx (461030)
Bilangan saham terbitan setakat August 2026: 0
Menurut laporan kewangan terkini dan harga saham IMBdx, bilangan saham terbitan semasa ialah 0. Pada akhir August 2026, syarikat mempunyai 0 saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk IMBdx (461030) dari 2026 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
253.90M -
US
396.00M -
US
62.19M -
NL
483.58M -
AU
- -
CH